Subramanyam Padma, Janarthanan R, Palaniswamy Shanmuga Sundaram
Department of Nuclear Medicine and Molecular Imaging, Amrita Institute of Medical Sciences, Cochin, Kerala, India.
Department of Plastic and Reconstructive Surgery, Amrita Institute of Medical Sciences, Cochin, Kerala, India.
Indian J Nucl Med. 2022 Jan-Mar;37(1):1-6. doi: 10.4103/ijnm.ijnm_123_21. Epub 2022 Mar 25.
Despite the lymphatic system being so important and extensive, the field of lymphatic diseases, research is still very young. Lymphedema is a progressively debilitating condition with no known "cure." Specific pathologies that could benefit from improved lymphatic drainage by advanced super surgical techniques or engineered tissue transfer are being sought. Microsurgical techniques like lymphovenous bypass and anastomosis have spurred interest as they tend to physiologically restore the damaged lymphatic channels and may be a key to permanent cure. The latest in the field is vascularized lymph node transfer (VLNT), indicated in post mastectomy or other post operative settings producing disruption of regional lymphatic channels and draining lymph nodes. Autologous healthy lymph nodes are transferred along with surrounding fat and vascular pedicle to the affected limb in a bid to promote lymphangiogenesis. Lymphoscintigraphy (LS) is a simple, noninvasive nuclear technique used in identifying upper or lower limb lymphatic dysfunction and obstruction with a high degree of sensitivity. Quantitative LS is extremely useful in follow-up assessment of lymphedema postmanual lymphatic drainage (MLD) or other forms of medical management.
We hypothesize that LS can document perinodal lymphangiogenesis post VLNT.
Three cases of acquired lymphedema (suspected filariasis and postmastectomy conditions) who underwent VLNT in our institute were prospectively studied with LS. The imaging findings highlight the subtle lymphatic regeneration along with the vascularized graft in all three patients during the early postoperative period.
This is the first (pilot) study documenting early spontaneous perinodal lymphangiogenesis after VLNT in human subjects.Tc Nanocolloid LS has been found to be incremental in demonstrating early lymphangiogenesis.
尽管淋巴系统非常重要且分布广泛,但淋巴疾病领域的研究仍处于起步阶段。淋巴水肿是一种逐渐使人衰弱的病症,尚无已知的“治愈方法”。人们正在寻找特定的病理状况,这些状况可通过先进的超级外科技术或工程组织移植改善淋巴引流而受益。诸如淋巴静脉旁路和吻合术等显微外科技术引发了人们的兴趣,因为它们倾向于在生理上修复受损的淋巴管,可能是实现永久治愈的关键。该领域的最新技术是带血管蒂淋巴结转移术(VLNT),适用于乳房切除术后或其他导致区域淋巴管和引流淋巴结中断的术后情况。自体健康淋巴结连同周围脂肪和血管蒂一起转移到受影响的肢体,以促进淋巴管生成。淋巴闪烁显像(LS)是一种简单的非侵入性核技术,用于识别上肢或下肢淋巴功能障碍和梗阻,具有高度的敏感性。定量LS在手法淋巴引流(MLD)或其他形式的医学管理后对淋巴水肿的随访评估中极为有用。
我们假设LS可以记录VLNT术后淋巴结周围的淋巴管生成情况。
对我院3例接受VLNT的后天性淋巴水肿患者(疑似丝虫病和乳房切除术后情况)进行了前瞻性LS研究。影像学结果突出显示了所有3例患者在术后早期淋巴管的细微再生以及带血管蒂移植物。
这是第一项记录人类受试者VLNT术后早期自发性淋巴结周围淋巴管生成的(试点)研究。已发现锝纳米胶体LS在显示早期淋巴管生成方面具有增量作用。